Correlation Between Equillium and Gain Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equillium and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Gain Therapeutics, you can compare the effects of market volatilities on Equillium and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Gain Therapeutics.

Diversification Opportunities for Equillium and Gain Therapeutics

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Equillium and Gain is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of Equillium i.e., Equillium and Gain Therapeutics go up and down completely randomly.

Pair Corralation between Equillium and Gain Therapeutics

Allowing for the 90-day total investment horizon Equillium is expected to generate 1.25 times more return on investment than Gain Therapeutics. However, Equillium is 1.25 times more volatile than Gain Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Gain Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  84.00  in Equillium on September 12, 2024 and sell it today you would lose (14.00) from holding Equillium or give up 16.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Equillium  vs.  Gain Therapeutics

 Performance 
       Timeline  
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Gain Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Gain Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Gain Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Equillium and Gain Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equillium and Gain Therapeutics

The main advantage of trading using opposite Equillium and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.
The idea behind Equillium and Gain Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account